德尔塔
您当前所在位置:首页 > 分析科学 > 新品上市

「同位素标记抑制剂」Chlorogenic acid-13C3

发布时间:2025-06-10     作者:德尔塔生物   分享到:

【产品介绍】:

生物活性:Chlorogenic acid-13C3 (Heriguard-13C3; NSC-407296-13C3) is 13C- and 15N-labeled Chlorogenic acid (HY-N0055). Chlorogenic acid is a major phenolic compound in Lonicera japonica Thunb.. It plays several important and therapeutic roles such as antioxidant activity, antibacterial, hepatoprotective, cardioprotective, anti-inflammatory, antipyretic, neuroprotective, anti-obesity, antiviral, anti-microbial, anti-hypertension[1][2].
体外研究(In Vitro):氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注,因为它可能影响药物的药代动力学和代谢谱[1]。
德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.
分子量:357.29
Formula:C1313C3H18O9
非标记 CAS:327-97-9
中文名称:绿原酸-13C3;3-咖啡酰奎尼酸-13C3;咖啡单宁酸-13C3;咖啡酰奎尼酸-13C3;氯吉酸-13C3;绿源酸-13C3
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
Data Sheet (529 KB)
产品使用指南 (1538 KB)
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
 [Content Brief]